Advertisement

Topics

Optimal Duration of Endocrine Therapy for Breast Cancer

08:00 EDT 13 Mar 2018 | Medscape

According to a new study, five years of extended adjuvant letrozole for early breast cancer was not superior to 2.5 years.
Journal of the National Cancer Institute

Original Article: Optimal Duration of Endocrine Therapy for Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Optimal Duration of Endocrine Therapy for Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...